Ann: Imugene completes $90 M placement and launches $5 M SPP, page-7

  1. 2,315 Posts.
    lightbulb Created with Sketch. 648
    ASX Announcement
    IMUGENE COMPLETES STRONGLY SUPPORTED $90M PLACEMENT & LAUNCHES $5M SPP___________________________________________________________________
    •• The placement received outstanding cornerstone interest from specialist biotech institutional investors
    *Share Purchase Plan (SPP) for existing eligible shareholders to raise up to a further $5 million at $0.30 per share
    *Participants in the placement and SPP will receive 1 free option for every 2 shares received in the offer – the options are intended to be listed on the ASX with an exercise price of $0.45 and expiration of 31 August 2024
    * The capital raised will be used to fund Imugene’s clinical trial pipeline through to the end of 2025, with partnering and licensing opportunities and R&D rebates expected to extend the cash runway sophisticated investors at $0.30 per share
    Firm commitments received for $90 million placement to new and existing institutional
    Last edited by Kluck: 29/07/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
37.5¢
Change
0.005(1.35%)
Mkt cap ! $82.39M
Open High Low Value Volume
37.0¢ 37.5¢ 36.0¢ $342.2K 938.4K

Buyers (Bids)

No. Vol. Price($)
1 488 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 12566 2
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.